These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 11714802)

  • 1. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
    Boackle RJ; Connor MH; Vesely J
    Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
    Busby TF; Ingham KC
    Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
    Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
    Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity.
    Sárvári M; Vágó I; Wéber CS; Nagy J; Gál P; Mák M; Kósa JP; Závodszky P; Pázmány T
    J Neuroimmunol; 2003 Apr; 137(1-2):12-8. PubMed ID: 12667643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of C1 with HIV-1.
    Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
    Behring Inst Mitt; 1993 Dec; (93):165-70. PubMed ID: 8172563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.
    Li M; Ager RR; Fraser DA; Tjokro NO; Tenner AJ
    Mol Immunol; 2008 Jun; 45(11):3244-52. PubMed ID: 18400300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical characterization and location of ionic interactions involved in the assembly of the C1 complex of human complement.
    Illy C; Thielens NM; Arlaud GJ
    J Protein Chem; 1993 Dec; 12(6):771-81. PubMed ID: 8136028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
    Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation by cross-linked truncated and chimeric full-length beta-amyloid.
    Cribbs DH; Velazquez P; Soreghan B; Glabe CG; Tenner AJ
    Neuroreport; 1997 Nov; 8(16):3457-62. PubMed ID: 9427307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
    Webster S; Bonnell B; Rogers J
    Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.
    Ebenbichler CF; Thielens NM; Vornhagen R; Marschang P; Arlaud GJ; Dierich MP
    J Exp Med; 1991 Dec; 174(6):1417-24. PubMed ID: 1744579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activation of the classical pathway of complement by human neutrophil defensins.
    van den Berg RH; Faber-Krol MC; van Wetering S; Hiemstra PS; Daha MR
    Blood; 1998 Nov; 92(10):3898-903. PubMed ID: 9808583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.